ARLENE CARUNGCONG-OTADO: Open Payments
NPI 1407193121 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,858 in 92 payments from 9 companies in 2025. Trend: 2023 $2,526 · 2024 $2,326 · 2025 $1,858
Food & beverage: $1,858
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 26 | $747 |
| Collegium Pharmaceutical, Inc. | 32 | $484 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $299 |
| PROTEGA PHARMACEUTIALS INC | 6 | $114 |
| ABBVIE INC. | 4 | $76 |
| IBSA Pharma Inc. | 3 | $65 |
| SCILEX PHARMACEUTICALS INC. | 2 | $36 |
| PFIZER INC. | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: PROLATE, RELISTOR, Belbuca, Nucynta, XTAMPZA, ROXYBOND, TANLOR, Tirosint.
Industry payments across NV — which companies pay providers there.
